Trading Ideas Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen Other stock markets 09:50:00 05/12/2025 pm IST			5-day change	1st Jan Change
2,032.00 ^DKK	-1.45%		+0.05%	+36.15%

05/12	Genmab A/S Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025 09:45 AM
04/12	Genmab Closes $2.5 Billion Senior Notes Offering	MT

Trading Ideas

GENMAB A/S: A support level that should be taken advantage of	31/03
GENMAB A/S: A trend reversal can be anticipated	27/24/27
GENMAB A/S: The comeback of an upward trend can be anticipated	11/24/11
GENMAB A/S: Expectation of a turn-around	25/24/25
GENMAB A/S: Expectation of a turn-around	04/24/04
GENMAB A/S: The comeback of an upward trend can be anticipated	08/23/08
GENMAB A/S: Technically solid	16/22/16
GENMAB A/S: Buyers are coming back	12/22/12
GENMAB A/S: Comeback of a rising trend?	31/22/31
GENMAB A/S: The underlying trend is to the upside	15/20/15
GENMAB A/S: The underlying trend is to the upside	31/20/31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Genmab advances on earnings strength and pipeline while lower valuation opens upside

Genmab advances on earnings strength and pipeline while lower valuation opens upside

November 07, 2025 at 08:31 pm IST

Genmab: From now on, courage to the most patient

April 01, 2025 at 08:27 pm IST

Genmab: From now on, courage to the most patient

As early as today, start finding the best investment opportunities!